Enablement Unchanged: Amgen v. Sanofi and the Future of Software Patents | Levenfeld Pearlstein, LLC

In a unanimous ruling, the Supreme Court of the United States (SCOTUS) addressed the enablement requirement under Section 112 of the Patent Act, placing this into sharper focus with the...

Related Keywords

Delaware ,United States ,Justice Neil Gorsuch ,Justice Gorsuch ,Us Court ,District Court ,Amgen ,Supreme Court ,Patent Act ,Regeneron Pharmaceutical ,Federal Circuit ,Neil Gorsuch ,